ORGANOGENESIS HOLDINGS INC
NASDAQ: ORGO (Organogenesis Holdings Inc.)
Kemas kini terakhir: 11 jam lalu3.10
0.07 (2.31%)
| Penutupan Terdahulu | 3.03 |
| Buka | 3.03 |
| Jumlah Dagangan | 306,691 |
| Purata Dagangan (3B) | 716,241 |
| Modal Pasaran | 389,750,592 |
| Harga / Jualan (P/S) | 0.930 |
| Harga / Buku (P/B) | 1.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | -1.62% |
| Margin Operasi (TTM) | 5.42% |
| EPS Cair (TTM) | -0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 289.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 38.65% |
| Nisbah Semasa (MRQ) | 3.09 |
| Aliran Tunai Operasi (OCF TTM) | 13.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 13.47 M |
| Pulangan Atas Aset (ROA TTM) | 1.64% |
| Pulangan Atas Ekuiti (ROE TTM) | -2.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Organogenesis Holdings Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.83 |
|
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 46.36% |
| % Dimiliki oleh Institusi | 50.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Soleus Capital Management, L.P. | 30 Sep 2024 | 11,839,876 |
| Aqr Capital Management Llc | 30 Sep 2024 | 2,710,606 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 Nov 2024 | Pengumuman | Organogenesis Expands Manufacturing Capacity to Support Future Growth |
| 15 Nov 2024 | Pengumuman | Organogenesis Commends Final LCDs |
| 12 Nov 2024 | Pengumuman | Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results |
| 12 Nov 2024 | Pengumuman | Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock |
| 11 Nov 2024 | Pengumuman | Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis |
| 16 Oct 2024 | Pengumuman | Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |